The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition

Executive Order Targets Prescription Drugs & Health Insurance to Promote Competition

July 19, 2021

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Read the complete Executive Order online.

You Might Also Like
  • White House Preparing Order that Would Cut Drug Prices for Medicare
  • Trump Says He Will Allow States to Import Prescription Drugs to Lower Costs
  • Cephalon, U.S. States Reach $125 Million Settlement Over Generic Drugs

The ACR supports efforts to reduce the cost of high-priced treatments for patients with rheumatic diseases, as long as the ability of rheumatologists and healthcare teams to provide safe and effective treatment is not restricted.² The ACR will also be monitoring implementation efforts and be prepared to advocate against the Most Favored Nation (MFN) model if the Centers for Medicare & Medicaid Services introduces it again in response to this Executive Order.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Fact Sheet: Executive order on promoting competition in the American economy. WhiteHouse.gov. 2021 Jul 9.
  2. American College of Rheumatology. 2021 ACR top priorities. 2021.

Pages: 1 2 | Single Page

Filed Under: Drug Updates, Legislation & Advocacy, Professional Topics Tagged With: Biosimilars, costs, drug prices, executive order, Health Insurance

You Might Also Like:
  • White House Preparing Order that Would Cut Drug Prices for Medicare
  • Trump Says He Will Allow States to Import Prescription Drugs to Lower Costs
  • Cephalon, U.S. States Reach $125 Million Settlement Over Generic Drugs
  • Keeping the Pressure on Congress: ACR Opposes Medicare Payment Adjustment Plan, Executive Order

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)